Myriam Chentouf

Myriam Chentouf is currently working as an Ingénieur de Recherche at IRCM - Institut de Recherche en Cancérologie de Montpellier, specializing in the characterization, production, purification of antibodies, as well as the identification and selection of new therapeutic tools through Phage Display. Prior to this, Myriam was an ATER at CPID, focusing on the role of cytokines in type 2 diabetes pathogenesis. Myriam completed their Doctorat at CPBS, studying the mechanisms of action of the recombinant antibody 13B8.2 anti-CD4. Myriam completed their education at the University of Montpellier with a degree in Doctorat in Biology and Health, and at Université Marseille St Jérôme with a DESS in Biology Biotechnology.